Globus Medical (GMED) Stock Analysis & Winston Score

Globus Medical makes medical devices used in spine surgery. Its main products are implants, screws, rods, and robotic surgical systems that help surgeons fix broken or damaged spines. The company sells primarily to hospitals and spine surgeons across the United States and in international markets. Globus makes money by selling its hardware directly to hospitals, often supported by a large sales force that works closely with surgeons. In 2023, the company merged with NuVasive, making it one of the largest pure-play spine device companies in the world, with combined annual revenue exceeding $2 billion. Its competitive position comes from strong surgeon relationships, a broad product portfolio, and its Excelsius GPS robotic platform, which ties surgeons to its ecosystem. The key growth driver is expanding robotic-assisted surgery adoption, but integrating the NuVasive merger smoothly while managing higher debt levels remains the main near-term risk.